Each year billions of dollars are wasted as drug developers struggle to effectively manage in vivo studies. Poor operations and data management slows progress and reduces data quality. 90% of all compounds that make it to Phase I clinical trials fail to gain FDA approval. Improving in vivo study management can help speed drugs to market and get wrong drugs out of the pipeline faster. Learn about challenges faced in animal-lab research and how an effective SaaS informatics platforms can help bring order to chaos.